These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 18452537)

  • 21. The prognostic significance of nuclear CSE1L in urinary bladder urothelial carcinomas.
    Chang CC; Tai CJ; Su TC; Shen KH; Lin SH; Yeh CM; Yeh KT; Lin YM; Jiang MC
    Ann Diagn Pathol; 2012 Oct; 16(5):362-8. PubMed ID: 22476051
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rsf-1/HBXAP overexpression is independent of gene amplification and is associated with poor outcome in patients with urinary bladder urothelial carcinoma.
    Liang PI; Wu LC; Sheu JJ; Wu TF; Shen KH; Wang YH; Wu WR; Shiue YL; Huang HY; Hsu HP; Chen YH; Chen LT; Li CF; Liao AC
    J Clin Pathol; 2012 Sep; 65(9):802-7. PubMed ID: 22685262
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Urothelial hyperplastic lesion with endophytic growth pattern: a clinicopathologic study].
    Xiao L; Wang CF; Zhu XZ; Yin YL; Chen Y; Lu C; Yu B
    Zhonghua Bing Li Xue Za Zhi; 2011 May; 40(5):319-23. PubMed ID: 21756826
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Loss of adipocyte-type fatty acid binding protein and other protein biomarkers is associated with progression of human bladder transitional cell carcinomas.
    Celis JE; Ostergaard M; Basse B; Celis A; Lauridsen JB; Ratz GP; Andersen I; Hein B; Wolf H; Orntoft TF; Rasmussen HH
    Cancer Res; 1996 Oct; 56(20):4782-90. PubMed ID: 8840999
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic significance of heat shock proteins in urothelial carcinoma of the urinary bladder.
    Yu HJ; Chang YH; Pan CC
    Histopathology; 2013 Apr; 62(5):788-98. PubMed ID: 23425286
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reciprocal expression of bcl-2 and p53 oncoproteins in urothelial dysplasia and carcinoma of the urinary bladder.
    Li B; Kanamaru H; Noriki S; Yamaguchi T; Fukuda M; Okada K
    Urol Res; 1998; 26(4):235-41. PubMed ID: 9759996
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Annexin-I overexpression is associated with tumour progression and independently predicts inferior disease-specific and metastasis-free survival in urinary bladder urothelial carcinoma.
    Li CF; Shen KH; Huang LC; Huang HY; Wang YH; Wu TF
    Pathology; 2010 Jan; 42(1):43-9. PubMed ID: 20025479
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The prevalence and clinicopathologic correlate of p16INK4a, retinoblastoma and p53 immunoreactivity in locally advanced urinary bladder cancer.
    Tzai TS; Tsai YS; Chow NH
    Urol Oncol; 2004; 22(2):112-8. PubMed ID: 15082007
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A-FABP, a candidate progression marker of human transitional cell carcinoma of the bladder, is differentially regulated by PPAR in urothelial cancer cells.
    Boiteux G; Lascombe I; Roche E; Plissonnier ML; Clairotte A; Bittard H; Fauconnet S
    Int J Cancer; 2009 Apr; 124(8):1820-8. PubMed ID: 19115207
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ectopic WWOX Expression Inhibits Growth of 5637 Bladder Cancer Cell In Vitro and In Vivo.
    Li G; Sun L; Mu Z; Huang Y; Fu C; Hu B
    Cell Biochem Biophys; 2015 Nov; 73(2):417-425. PubMed ID: 27352332
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression of bcl-2 and p53 oncoproteins in schistosomiasis-associated transitional and squamous cell carcinoma of urinary bladder.
    Chaudhary KS; Lu QL; Abel PD; Khandan-Nia N; Shoma AM; el Baz M; Stamp GW; Lalani EN
    Br J Urol; 1997 Jan; 79(1):78-84. PubMed ID: 9043502
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Overexpression of p53 protein and its significance for recurrent progressive bladder tumours.
    Underwood MA; Reeves J; Smith G; Gardiner DS; Scott R; Bartlett J; Cooke TG
    Br J Urol; 1996 May; 77(5):659-66. PubMed ID: 8689106
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CD147 overexpression allows an accurate discrimination of bladder cancer patients' prognosis.
    Afonso J; Longatto-Filho A; Baltazar F; Sousa N; Costa FE; Morais A; Amaro T; Lopes C; Santos LL
    Eur J Surg Oncol; 2011 Sep; 37(9):811-7. PubMed ID: 21733655
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association of oncofetal protein expression with clinical outcomes in patients with urothelial carcinoma of the bladder.
    Xylinas E; Cha EK; Khani F; Kluth LA; Rieken M; Volkmer BG; Hautmann R; Küfer R; Chen YT; Zerbib M; Rubin MA; Scherr DS; Shariat SF; Robinson BD
    J Urol; 2014 Mar; 191(3):830-41. PubMed ID: 23994370
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Increased PD-L1 expression in high-grade bladder cancer with squamous cell differentiation in Bulgarian and French patients' samples.
    Gulinac M; Dikov D; Velikova T; Belovezhdov V
    Ann Diagn Pathol; 2020 Dec; 49():151640. PubMed ID: 33069081
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High expression of Chitinase 3-like-1 is an unfavorable prognostic factor in urothelial carcinoma of upper urinary tract and urinary bladder.
    Lee YE; Chan TC; Tian YF; Liang PI; Shiue YL; Chen YS; He HL
    Urol Oncol; 2019 May; 37(5):299.e7-299.e18. PubMed ID: 30660494
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fascin determination in urothelial carcinomas of the urinary bladder: a marker of invasiveness.
    Karasavvidou F; Barbanis S; Pappa D; Moutzouris G; Tzortzis V; Melekos MD; Koukoulis G
    Arch Pathol Lab Med; 2008 Dec; 132(12):1912-5. PubMed ID: 19061289
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic significance of Her2/neu overexpression in patients with muscle invasive urinary bladder cancer treated with radical cystectomy.
    Kolla SB; Seth A; Singh MK; Gupta NP; Hemal AK; Dogra PN; Kumar R
    Int Urol Nephrol; 2008; 40(2):321-7. PubMed ID: 17899426
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Expressions of WWOX and CD133 in colorectal cancer and their clinical significance].
    Zhu B; Wang D; Zhang Q; Wu S; Yu L; Tao Y
    Nan Fang Yi Ke Da Xue Xue Bao; 2015 Nov; 35(11):1586-90. PubMed ID: 26607080
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cell Cycle Markers in the Evaluation of Bladder Cancer.
    da Silva JNL; Ranzi AD; Carvalho CT; Scheide TV; Strey YTM; Graziottin TM; Bica CG
    Pathol Oncol Res; 2020 Jan; 26(1):175-181. PubMed ID: 29524168
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.